Consensus Interferon: Tailored Therapy and the Impact of Adherence

  title={Consensus Interferon: Tailored Therapy and the Impact of Adherence},
  author={S. A. Gonzalez},
  journal={Digestive Diseases and Sciences},
A successful course of antiviral therapy in patients with chronic hepatitis C virus (HCV) infection is durable and can result in significant long-term benefit; however, many patients who undergo combination therapy with pegylated interferon alfa (PegIFN) and ribavirin (RBV) ultimately fail and develop persistent viremia. Our ability to achieve a sustained virologic response (SVR) is especially limited in patients with genotype 1 infection. Additional factors that characterize the most… CONTINUE READING